All PlansAdministrativeLow impact
Voluntary nationwide recall: Clonazepam (Endo – July)
UPMC Health Plan·Pharmacy·Pharmacy
We identified it
Aug 7, 2026
Summary
Endo USA Inc. has issued a voluntary nationwide recall of one lot of Clonazepam Orally Disintegrating Tablets 0.25 mg due to mislabeled cartons showing 0.125 mg strength. The actual tablets contain the correct 0.25 mg dose, but patients may be confused by incorrect labeling. Billing teams should be aware that affected patients may contact the practice or experience medication-related issues, though no adverse events have been reported as of July 16.
Action Required
No specific billing action is required. This is a pharmaceutical safety recall notification. Clinical staff should be made aware to: (1) Alert patients who received this lot if dispensed by the practice; (2) Direct patients to call Inmar Inc. at 1-877-890-0765 (Monday-Friday, 9 a.m.-5 p.m. ET) or visit the FDA website for recall details. No claims processing changes, prior authorization updates, or billing code modifications are needed. Billing team should note this recall for reference if patients call with medication-related questions.